263 related articles for article (PubMed ID: 28364387)
41. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
[TBL] [Abstract][Full Text] [Related]
42. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
[TBL] [Abstract][Full Text] [Related]
43. Individual Preferences for Child and Adolescent Vaccine Attributes: A Systematic Review of the Stated Preference Literature.
Michaels-Igbokwe C; MacDonald S; Currie GR
Patient; 2017 Dec; 10(6):687-700. PubMed ID: 28474295
[TBL] [Abstract][Full Text] [Related]
44. Are Efficient Designs Used in Discrete Choice Experiments Too Difficult for Some Respondents? A Case Study Eliciting Preferences for End-of-Life Care.
Flynn TN; Bilger M; Malhotra C; Finkelstein EA
Pharmacoeconomics; 2016 Mar; 34(3):273-84. PubMed ID: 26589411
[TBL] [Abstract][Full Text] [Related]
45. Attribute development and level selection for a discrete choice experiment to elicit the preferences of health care providers for capitation payment mechanism in Kenya.
Obadha M; Barasa E; Kazungu J; Abiiro GA; Chuma J
Health Econ Rev; 2019 Oct; 9(1):30. PubMed ID: 31667632
[TBL] [Abstract][Full Text] [Related]
46. Patient Preferences for the Treatment of Basal Cell Carcinoma: A Mapping Review of Discrete Choice Experiments.
Neal DE; Feit EM; Etzkorn JR
Dermatol Surg; 2018 Aug; 44(8):1041-1049. PubMed ID: 30045140
[TBL] [Abstract][Full Text] [Related]
47. Tailoring chemotherapy supply according to patients' preferences: a quantitative method in colorectal cancer care.
Rosato R; Di Cuonzo D; Ritorto G; Fanchini L; Bustreo S; Racca P; Pagano E
Curr Med Res Opin; 2020 Jan; 36(1):73-81. PubMed ID: 31535573
[No Abstract] [Full Text] [Related]
48. A novel design process for selection of attributes for inclusion in discrete choice experiments: case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke.
De Brún A; Flynn D; Ternent L; Price CI; Rodgers H; Ford GA; Rudd M; Lancsar E; Simpson S; Teah J; Thomson RG
BMC Health Serv Res; 2018 Jun; 18(1):483. PubMed ID: 29929523
[TBL] [Abstract][Full Text] [Related]
49. Decision-makers' preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity.
Linley WG; Hughes DA
Pharmacoeconomics; 2013 Apr; 31(4):345-55. PubMed ID: 23516033
[TBL] [Abstract][Full Text] [Related]
50. Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments.
Wulandari LPL; He SY; Fairley CK; Bavinton BR; Marie-Schmidt H; Wiseman V; Guy R; Tang W; Zhang L; Ong JJ
EClinicalMedicine; 2022 Sep; 51():101507. PubMed ID: 35844771
[TBL] [Abstract][Full Text] [Related]
51. The Feasibility and Usability of a Ranking Tool to Elicit Patient Preferences for the Treatment of Trigger Finger.
Shapiro LM; Eppler SL; Kamal RN
J Hand Surg Am; 2019 Jun; 44(6):480-486.e1. PubMed ID: 30797655
[TBL] [Abstract][Full Text] [Related]
52. Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.
Morrish N; Snowsill T; Dodman S; Medina-Lara A
Med Decis Making; 2024 Apr; 44(3):252-268. PubMed ID: 38323553
[TBL] [Abstract][Full Text] [Related]
53. Do patients prefer mesh or anterior colporrhaphy for primary correction of anterior vaginal wall prolapse: a labelled discrete choice experiment.
Notten K; Essers BA; Weemhoff M; Rutten A; Donners J; van Gestel I; Kruitwagen R; Roovers J; Dirksen CD
BJOG; 2015 May; 122(6):873-880. PubMed ID: 25041082
[TBL] [Abstract][Full Text] [Related]
54. Stakeholder Engagement in Designing Attributes for a Discrete Choice Experiment With Policy Implications: An Example of 2 Swiss Studies on Healthcare Delivery.
Föhn Z; Nicolet A; Marti J; Kaufmann C; Balthasar A
Value Health; 2023 Jun; 26(6):925-933. PubMed ID: 36646277
[TBL] [Abstract][Full Text] [Related]
55. Keeping an eye on cost: What can eye tracking tell us about attention to cost information in discrete choice experiments?
Genie MG; Ryan M; Krucien N
Health Econ; 2023 May; 32(5):1101-1119. PubMed ID: 36737875
[TBL] [Abstract][Full Text] [Related]
56. Developing attributes and attribute-levels for a discrete choice experiment on micro health insurance in rural Malawi.
Abiiro GA; Leppert G; Mbera GB; Robyn PJ; De Allegri M
BMC Health Serv Res; 2014 May; 14():235. PubMed ID: 24884920
[TBL] [Abstract][Full Text] [Related]
57. Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies.
Ettinger AB; Carter JA; Rajagopalan K
Epilepsy Behav; 2018 Mar; 80():247-253. PubMed ID: 29433949
[TBL] [Abstract][Full Text] [Related]
58. Preferences for Palliative and End-of-Life Care: A Systematic Review of Discrete Choice Experiments.
Xia Q; Kularatna M; Virdun C; Button E; Close E; Carter HE
Value Health; 2023 Dec; 26(12):1795-1809. PubMed ID: 37543206
[TBL] [Abstract][Full Text] [Related]
59. Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013.
Mansfield C; Tangka FK; Ekwueme DU; Smith JL; Guy GP; Li C; Hauber AB
Prev Chronic Dis; 2016 Feb; 13():E27. PubMed ID: 26916898
[TBL] [Abstract][Full Text] [Related]
60. Assessment of patients' preferences for new anticancer drugs in China: a best-worst discrete choice experiment on three common cancer types.
Feng Z; Meng J; Sun Y; Xie T; Lu W; Wang G; Geng J
BMJ Open; 2023 Jun; 13(6):e072469. PubMed ID: 37270199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
